Kodiak Sciences Ownership

KOD Stock  USD 6.80  0.05  0.74%   
Kodiak Sciences maintains a total of 52.62 Million outstanding shares. The majority of Kodiak Sciences outstanding shares are owned by institutional investors. These third-party entities are usually referred to as non-private investors looking to shop for positions in Kodiak Sciences to benefit from reduced commissions. Consequently, institutional holders are subject to a different set of regulations than regular investors in Kodiak Sciences. Please pay attention to any change in the institutional holdings of Kodiak Sciences as this could imply that something significant has changed or is about to change at the company. Please note that no matter how many assets the company has, if the real value of the firm is less than the current market value, you may not be able to make money on it.
 
Shares in Circulation  
First Issued
2017-03-31
Previous Quarter
52.6 M
Current Value
52.6 M
Avarage Shares Outstanding
42.6 M
Quarterly Volatility
12.8 M
 
Covid
Please note, institutional investors have a lot of resources and new technology at their disposal. They can put in a lot of research and financial analysis when reviewing investment options. There are many different types of institutional investors, including banks, hedge funds, insurance companies, and pension plans. One of the main advantages they have over retail investors is the fees paid for trades. As they are buying in large quantities, they can manage their cost more effectively.
  
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Kodiak Sciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons.
For information on how to trade Kodiak Stock refer to our How to Trade Kodiak Stock guide.

Kodiak Stock Ownership Analysis

About 78.0% of the company shares are owned by institutional investors. The company has price-to-book ratio of 1.92. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Kodiak Sciences recorded a loss per share of 3.64. The entity had not issued any dividends in recent years. Kodiak Sciences Inc., a clinical stage biopharmaceutical company, researches, develops, and commercializes therapeutics to treat retinal diseases. Kodiak Sciences Inc. was incorporated in 2009 and is based in Palo Alto, California. Kodiak Sciences operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 101 people. To find out more about Kodiak Sciences contact the company at 650 281 0850 or learn more at https://kodiak.com.

Kodiak Stock Institutional Investors

Have you ever been surprised when a price of an equity instrument such as Kodiak Sciences is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Kodiak Sciences backward and forwards among themselves. Kodiak Sciences' institutional investor refers to the entity that pools money to purchase Kodiak Sciences' securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
Shares
Jacobs Levy Equity Management, Inc.2024-09-30
580.8 K
Silverarc Capital Management, Llc2024-09-30
500 K
Dimensional Fund Advisors, Inc.2024-09-30
495.2 K
Hudson Bay Capital Management Lp2024-09-30
493.5 K
Ikarian Capital, Llc2024-09-30
476.6 K
Bruce & Co Inc2024-09-30
423 K
Morgan Stanley - Brokerage Accounts2024-09-30
361.2 K
Two Sigma Advisers, Llc2024-09-30
333.3 K
Goldman Sachs Group Inc2024-09-30
318.8 K
Baker Bros Advisors Lp2024-09-30
17.3 M
Blackrock Inc2024-09-30
3.9 M
Note, although Kodiak Sciences' institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Kodiak Sciences Insider Trading Activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Kodiak Sciences insiders, such as employees or executives, is commonly permitted as long as it does not rely on Kodiak Sciences' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Kodiak Sciences insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
 
Baker Bros. Advisors Lp over a week ago
Acquisition by Baker Bros. Advisors Lp of 42250 shares of Kodiak Sciences at 6.6036 subject to Rule 16b-3
 
Profusek Robert over a month ago
Acquisition by Profusek Robert of 40000 shares of Kodiak Sciences at 2.35 subject to Rule 16b-3
 
Baker Bros. Advisors Lp over three months ago
Acquisition by Baker Bros. Advisors Lp of 90674 shares of Kodiak Sciences at 5.9877 subject to Rule 16b-3
 
Perlroth Victor over three months ago
Acquisition by Perlroth Victor of 406000 shares of Kodiak Sciences at 2.49 subject to Rule 16b-3
 
Ehrlich Jason over six months ago
Disposition of 1205 shares by Ehrlich Jason of Kodiak Sciences at 7.21 subject to Rule 16b-3
 
Bancroft Charles A over six months ago
Acquisition by Bancroft Charles A of 40000 shares of Kodiak Sciences at 2.35 subject to Rule 16b-3
 
Borgeson John A. over six months ago
Disposition of 2874 shares by Borgeson John A. of Kodiak Sciences at 2.75 subject to Rule 16b-3
 
Borgeson John A. over six months ago
Disposition of 1558 shares by Borgeson John A. of Kodiak Sciences at 2.92 subject to Rule 16b-3
 
Borgeson John A. over six months ago
Disposition of 3025 shares by Borgeson John A. of Kodiak Sciences subject to Rule 16b-3
 
Dahiyat Bassil I over six months ago
Acquisition by Dahiyat Bassil I of 25000 shares of Kodiak Sciences subject to Rule 16b-3
 
Baker Bros. Advisors Lp over six months ago
Acquisition by Baker Bros. Advisors Lp of 11945 shares of Kodiak Sciences at 7.7488 subject to Rule 16b-3
 
Jason Ehrlich over six months ago
Disposition of 1205 shares by Jason Ehrlich of Kodiak Sciences at 7.21 subject to Rule 16b-3

Kodiak Sciences Outstanding Bonds

Kodiak Sciences issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Kodiak Sciences uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Kodiak bonds can be classified according to their maturity, which is the date when Kodiak Sciences has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.

Kodiak Sciences Corporate Filings

8K
14th of November 2024
Report filed with the SEC to announce major events that shareholders should know about
ViewVerify
F4
7th of August 2024
The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities
ViewVerify
23rd of April 2024
Other Reports
ViewVerify

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether Kodiak Sciences is a strong investment it is important to analyze Kodiak Sciences' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Kodiak Sciences' future performance. For an informed investment choice regarding Kodiak Stock, refer to the following important reports:
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Kodiak Sciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons.
For information on how to trade Kodiak Stock refer to our How to Trade Kodiak Stock guide.
You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Kodiak Sciences. If investors know Kodiak will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Kodiak Sciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(3.64)
Return On Assets
(0.27)
Return On Equity
(0.71)
The market value of Kodiak Sciences is measured differently than its book value, which is the value of Kodiak that is recorded on the company's balance sheet. Investors also form their own opinion of Kodiak Sciences' value that differs from its market value or its book value, called intrinsic value, which is Kodiak Sciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Kodiak Sciences' market value can be influenced by many factors that don't directly affect Kodiak Sciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Kodiak Sciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Kodiak Sciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Kodiak Sciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.